DGX

154.33

0.62% -0.96

Vorhandelsmarkt: 155.94 1.61 +1.04%

Quest Diagnostics Inc (DGX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$155.29

Offen:

$155.37

24-Stunden-Volumen:

543.64K

Relative Volume:

0.76

Marktkapitalisierung:

$17.23B

Einnahmen:

$9.35B

Nettoeinkommen (Verlust:

$840.00M

KGV:

23.17

EPS:

6.66

Netto-Cashflow:

$875.00M

1W Leistung:

-1.02%

1M Leistung:

+2.35%

6M Leistung:

+12.34%

1J Leistung:

+15.25%

1-Tages-Spanne:

$154.00

$156.24

1-Wochen-Bereich:

$153.55

$157.44

52-Wochen-Spanne:

$123.04

$160.95

Quest Diagnostics Inc Stock (DGX) Company Profile

Firmenname

Quest Diagnostics Inc

Sektor

Healthcare (1180)

Branche

Diagnostics & Research (57)

Telefon

(973) 520-2700

Adresse

500 PLAZA DRIVE, SECAUCUS

Mitarbeiter

48,000

Twitter

@QuestDX

Nächster Verdiensttermin

2024-10-22

Neueste SEC-Einreichungen

DGX's Discussions on Twitter

Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-08-28	Fortgesetzt	Evercore ISI	In-line
2024-07-10	Hochstufung	Citigroup	Neutral → Buy
2024-02-26	Eingeleitet	Leerink Partners	Market Perform
2024-02-07	Hochstufung	Jefferies	Hold → Buy
2024-01-03	Eingeleitet	Barclays	Equal Weight
2023-12-12	Hochstufung	BofA Securities	Neutral → Buy
2023-06-29	Eingeleitet	Piper Sandler	Neutral
2023-05-02	Herabstufung	BofA Securities	Buy → Neutral
2023-04-03	Hochstufung	Citigroup	Sell → Neutral
2023-01-23	Eingeleitet	Evercore ISI	In-line
2022-11-17	Herabstufung	Citigroup	Neutral → Sell
2022-08-22	Fortgesetzt	Morgan Stanley	Equal-Weight
2022-04-04	Herabstufung	Citigroup	Buy → Neutral
2022-02-23	Herabstufung	UBS	Buy → Neutral
2022-02-02	Herabstufung	Jefferies	Buy → Hold
2022-01-28	Herabstufung	Deutsche Bank	Buy → Hold
2021-05-04	Hochstufung	UBS	Neutral → Buy
2021-03-12	Herabstufung	Robert W. Baird	Outperform → Neutral
2020-10-21	Hochstufung	Argus	Hold → Buy
2020-07-29	Hochstufung	KeyBanc Capital Markets	Sector Weight → Overweight
2020-07-14	Hochstufung	BofA Securities	Neutral → Buy
2020-06-09	Hochstufung	Wells Fargo	Underweight → Equal Weight
2020-06-02	Hochstufung	Deutsche Bank	Hold → Buy
2020-04-28	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2020-04-27	Hochstufung	Citigroup	Neutral → Buy
2020-04-27	Hochstufung	Wolfe Research	Underperform → Peer Perform
2020-03-27	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2020-01-08	Eingeleitet	Wells Fargo	Underweight
2020-01-07	Herabstufung	Barclays	Overweight → Equal Weight
2019-12-19	Hochstufung	BofA/Merrill	Underperform → Neutral
2019-07-15	Herabstufung	Goldman	Neutral → Sell
2019-04-02	Hochstufung	Jefferies	Hold → Buy
2019-03-18	Fortgesetzt	Credit Suisse	Neutral
2019-01-31	Herabstufung	Argus	Buy → Hold
2019-01-17	Eingeleitet	UBS	Neutral
2019-01-03	Herabstufung	BofA/Merrill	Neutral → Underperform
2018-12-03	Herabstufung	BofA/Merrill	Buy → Neutral
2018-11-30	Herabstufung	Goldman	Buy → Neutral

Alle ansehen

Quest Diagnostics Inc Aktie (DGX) Neueste Nachrichten

Nov 03, 2024

New York State Teachers Retirement System Trims Position in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat

Nov 03, 2024

Nov 02, 2024

DGX (Quest Diagnostics) PE Ratio : 20.87 (As of Nov. 02, 2024) - GuruFocus.com

Nov 02, 2024

Nov 01, 2024

Quest Diagnostics Inc. stock rises Friday, still underperforms market - MarketWatch

Nov 01, 2024

Quest Diagnostics Incorporated (NYSE:DGX) Shares Sold by State of Alaska Department of Revenue - MarketBeat

Nov 01, 2024

Oct 31, 2024

Quest Diagnostics Incorporated (NYSE:DGX) Holdings Lowered by Assenagon Asset Management S.A. - MarketBeat

Oct 31, 2024

Quest Diagnostics (NYSE:DGX) Upgraded at StockNews.com - MarketBeat

Oct 31, 2024

Oct 30, 2024

Quest Diagnostics' SVP sells shares worth $278,525 By Investing.com - Investing.com Canada

Oct 30, 2024

Quest Diagnostics' SVP sells shares worth $278,525 - Investing.com India

Oct 30, 2024

abrdn plc Has $71.50 Million Stock Position in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat

Oct 30, 2024

Oct 29, 2024

Quest Diagnostics Inc. stock rises Tuesday, still underperforms market - MarketWatch

Oct 29, 2024

Oct 28, 2024

Quest Diagnostics (NYSE:DGX) PT Raised to $165.00 - MarketBeat

Oct 28, 2024

Oct 27, 2024

DekaBank Deutsche Girozentrale Has $115.62 Million Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat

Oct 27, 2024

Oct 25, 2024

Director Gregg Vicky B increased direct ownership by 0.42% to 18,045 units (SEC Form 4) - Quantisnow

Oct 25, 2024

SVP & Chief Commercial Officer Delaney Mark E increased direct ownership by 0.08% to 5,023 units (SEC Form 4) - Quantisnow

Oct 25, 2024

Quest Diagnostics Incorporated (NYSE:DGX) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year - Yahoo Finance

Oct 25, 2024

FY2025 EPS Forecast for Quest Diagnostics Reduced by Analyst - MarketBeat

Oct 25, 2024

Quest Diagnostics Incorporated (DGX) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance

Oct 25, 2024

Raymond James & Associates Purchases 14,899 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat

Oct 25, 2024

Oct 24, 2024

Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch

Oct 24, 2024

Mizuho Boosts Quest Diagnostics (NYSE:DGX) Price Target to $174.00 - MarketBeat

Oct 24, 2024

Quest Diagnostics: Organic Growth Leads To Q3 Earnings Beat (NYSE:DGX) - Seeking Alpha

Oct 24, 2024

Quest Diagnostics (NYSE:DGX) Stock Rating Upgraded by Baird R W - MarketBeat

Oct 24, 2024

Zacks Industry Outlook Highlights Quest Diagnostics, Encompass Health, Amedisys and Addus HomeCare - Yahoo Finance

Oct 24, 2024

Quest Diagnostics to launch avian flu testing this month By Investing.com - Investing.com Canada

Oct 24, 2024

Quest Diagnostics Inc. stock outperforms competitors despite losses on the day - MarketWatch

Oct 23, 2024

My Quest Story – Martha Baer - StockTitan

Oct 23, 2024

Quest upgraded to outperform by Baird, sector momentum cited - MSN

Oct 23, 2024

Quest Diagnostics (NYSE:DGX) Sets New 12-Month High After Strong Earnings - MarketBeat

Oct 23, 2024

UBS Group Boosts Quest Diagnostics (NYSE:DGX) Price Target to $166.00 - MarketBeat

Oct 23, 2024

Quest Diagnostics stock hits 52-week high of $159.46 By Investing.com - Investing.com Canada

Oct 23, 2024

Quest Diagnostics (NYSE:DGX) Releases Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat

Oct 23, 2024

Quest Diagnostics set to launch a rapid lab test to detect avian influenza A H5 virus - Seeking Alpha

Oct 23, 2024

Quest Diagnostics Incorporated (NYSE:DGX) Q3 2024 Earnings Call Transcript - Insider Monkey

Oct 23, 2024

US lab operator Quest Diagnostics to launch bird flu test at end of October - Reuters.com

Oct 23, 2024

Quest Diagnostics (NYSE:DGX) Rating Increased to Outperform at Robert W. Baird - MarketBeat

Oct 23, 2024

Quest Diagnostics Awarded CDC Contracts for H5 Avian Influenza and Oropouche Virus Test Development - PR Newswire

Oct 23, 2024

Quest Diagnostics: Q3 Earnings Snapshot - The Advocate

Oct 23, 2024

Why Investors Shouldn't Be Surprised By Quest Diagnostics Incorporated's (NYSE:DGX) P/E - Simply Wall St

Oct 23, 2024